New Resource for Patients with GPA & MPA

A recently launched website provides up-to-date and easy to understand information about ANCA-Associated vasculitis (GPA and MPA) including diagnosis and management and patient perspectives.  ANCA101.com also offers information for patients and health care professionals. ...

Read more

Call for Submissions

The John Grube Foundation e.V., based in Hamburg, awards the “John Grube Prize” in honour of its namesake, who died young of granulomatosis with polyangiitis (GPA). The DGRH has been involved in the award since 2021 by appointing a board member to the foundation’s advisory board and providing a platform…...

Read more

Amgen Successfully Completes Acquisition of ChemoCentryx

TAVNEOS® (avacopan), a First-in-Class Medicine for Patients With Severe Active ANCA-Associated Vasculitis, Added to Inflammation Portfolio THOUSAND OAKS, Calif., (Oct. 20, 2022) – Amgen (NASDAQ: AMGN) today announced that it has successfully completed its previously announced acquisition of ChemoCentryx, Inc. (NASDAQ: CCXI), a biopharmaceutical company focused on orally administered therapeutics to treat…...

Read more

2021 V-RED Winners

Along with a first-place winner, there are two honorable mentions in the VF’s 2021 Recognizing Excellence in Diagnostics (V-RED) award program. Now in its eighth year, V-RED has grown into a powerful awareness campaign that recognizes medical providers worldwide for making a critical, early diagnosis of vasculitis. “Each year I…...

Read more